©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Gene RPA43 in Saccharomyces cerevisiae Encodes an Essential Subunit of RNA Polymerase I (*)

(Received for publication, May 24, 1995; and in revised form, August 9, 1995)

Pierre Thuriaux (§) Sylvie Mariotte Jean-Marie Buhler André Sentenac Loan Vu Bum-Soo Lee Masayasu Nomura

From the  (1)Service de Biochimie et Génétique Moleculaire, CEA Saclay, Bat. 142, F91191 GIF, Sur Yvette cedex, France (2)Department of Biological Chemistry, University of California, Irvine, California 92717

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

Yeast RNA polymerase I contains 14 distinct polypeptides, including A43, a component of about 43 kDa. The corresponding gene, RPA43, encodes a 326-amino acid polypeptide matching the peptidic sequence of two tryptic fragments isolated from A43. Gene inactivation leads to a lethal phenotype that is rescued by a plasmid containing the S ribosomal RNA gene fused to the GAL7 promoter, which allows the synthesis of S rRNA by RNA polymerase II in the presence of galactose. A screening for mutants rescued by the presence of GAL7-SrDNA identified a nonsense rpa43 allele truncating the protein at amino acid position 217. [^3H]Uridine pulse labeling showed that this mutation abolishes S rRNA synthesis without significant effects on the synthesis of 5 S RNA and tRNAs. These properties establish that A43 is an essential component of RNA polymerase I. This highly hydrophilic phosphoprotein has a strongly acidic carboxyl-terminal domain, and shows no homology to entries in current sequence data banks, including all the genetically identified components of the other two yeast RNA polymerases. RPA43 mapped next to RPA190, encoding the largest subunit of polymerase I. These genes are divergently transcribed and may thus share upstream regulatory elements ensuring their co-regulation.


INTRODUCTION

In the yeast Saccharomyces cerevisiae, as in other eukaryotes, the 25 S, 18 S, and 5.8 S ribosomal RNAs (rRNAs) derive from the post-transcriptional cleavage of a large pre-rRNA precursor, the S rRNA. The synthesis of that transcript accounts for about 60% of the total transcriptional activity of rapidly growing yeast cells. It takes place in the nucleolus and is catalyzed by RNA polymerase I (pol I), (^1)the more abundant of the three eukaryotic nuclear RNA polymerases (Warner, 1989; Nomura et al., 1993). In vertebrates, pol I operates in conjunction with two major transcription factors, UBF1 and SL1, forming a stable preinitiation complex (Reeder, 1992; Eberhard et al., 1993; Radebaugh et al., 1994; Zomerdijk et al., 1994). It has been established that pre-rRNA synthesis is the only essential function of yeast pol I, since the growth defect of pol I-defective mutants can be bypassed by placing the gene encoding the S rRNA under the control of a RNA polymerase II (pol II) promoter (Nogi et al., 1991a). This specialization of pol I enzyme is presumably a general property of eukaryotes.

Biochemical studies have shown that purified preparations of yeast pol I contain 14 distinct polypeptides (Buhler et al., 1976; Valenzuela et al., 1976; Carles et al., 1991). Five of them (ABC27, ABC23, ABC14.5, ABC10alpha, and ABC10beta) are common to all three nuclear RNA polymerases and the corresponding genes (RPB5, RPB6, RPB8, RPB10, and RPC10) have been characterized (Woychik et al., 1990; Woychik and Young, 1990; Treich et al., 1992; Lalo et al., 1993). Two other subunits (AC40 and AC19) are shared by pol I and pol III and are encoded by RPC40 and RPC19, respectively (Mann et al., 1987; Dequard-Chablat et al., 1991). Of the remaining seven pol I subunits, the two large ones, A190 and A135 (encoded by RPA190 and RPA135), have a sequence homology to the two large subunits of pol II, pol III, and bacterial RNA polymerases (Mémet et al., 1988; Yano and Nomura, 1991). These conserved or common nine subunits are essential for growth, as shown by the mutational inactivation of their genes (Young(1991) and Thuriaux and Sentenac(1992), and references therein). Remarkably, all but two of them (ABC14 and ABC10alpha) also have a structural equivalent in archeal RNA polymerases (Langer et al., 1995). This conservation obviously suggests that the corresponding polypeptides fulfill functions that are common to the central mechanism of transcription itself. Another subunit A12 (encoded by RPA12 or RRN4) has some homology to the B12.6 subunit of pol II (encoded by RPB9). RPA12 and RPB9 have been shown to be only conditionally essential (Woychik et al., 1991; Nogi et al., 1993).

In addition to this conserved or even common core of subunits shared by all three RNA polymerases, four polypeptides, A49, A43, A34, and A14, are found in pol I preparations only. The role of these polypeptides in the synthesis of rRNA is still poorly understood, but there is evidence that they are not strictly required for the catalytic activity of yeast pol I. Indeed, disrupting the A34- or A14-encoding genes hardly affects cellular growth (Smid et al., 1995), (^2)whereas a pol I preparation lacking both A49 and A43 retained catalytic activity in vitro as tested on nonspecific DNA templates (Hager et al., 1977). A49 has since then been shown to be a genuine pol I subunit that is partly dispensable in vivo (Liljelund et al., 1992). In the case of A43, the possibility of a fortuitous co-purification of that polypeptide with pol I could not be ruled out so far. The present work establishes that A43 is indeed an essential and specific component of yeast pol I, as shown by cloning and genetically characterizing the corresponding gene (RPA43) and by discovering that a mutation directly isolated as defective in ribosomal rRNA synthesis maps in RPA43.


MATERIALS AND METHODS

Plasmids and Strains

The RPA43 inserts isolated in the present work originated from three distinct laboratory strains of S. cerevisiae, X2180, AB320, and DBY476. The A43-1 clone was previously isolated by screening of a gt11 genomic library prepared from strain X2180 using anti-A43 antibodies (Riva et al., 1986). A 2.4-kb HindIII-EcoRI fragment of A43-1 was subcloned in pBluescriptKS+ (Stratagene) to generate pA43, whereas YCpA43-3 and YCpA43-6 were constructed by subcloning a BamHI fragment of 1.9 kb in YCp50. pA43Delta-LEU was generated by creating an additional BglII site a few base pairs downstream of the putative initiator triplet of RPA43 using polymerase chain reaction amplification (a GCC triplet encoding the Ala in position 7 of the predicted A43 amino acid sequence was replaced by TCT), and substituting the 0.6-kb BglII fragment thus produced by a 1.6-kb BamHI LEU2 cassette. pNOY16 (Wittekind et al., 1990) carries a genomic insert containing RPA190 and RPA43 derived from strain AB320 (Mémet et al., 1988). The 4.2-kb BamHI-SalI fragment of pNOY16 containing RPA43 was subcloned on pBluescriptKS+ and YCp50 to generate pBA43-12 and YCpA43-12, respectively.

RPA43 was also isolated from a genomic DNA library as a plasmid able to complement two rrn mutants originally classified in the complementation group called RRN12. Mutants defective in S rRNA synthesis were isolated from strain NOY418 (MATa ade2 ade3 leu2 ura3 lys2 CAN1/pNOY103) as described previously (Nogi et al., 1991b). These mutants can grow on galactose, but not on glucose. Mutants NOY639 and NOY640, corresponding to two distinct isolates but bearing the same nonsense allele (rpa43-1) were classified in complementation group RRN12. The yeast genomic library used for cloning of the RRN12(RPA43) gene contained DNA fragments obtained from partial MboI digestion of the chromosomal DNA (from strain DBY476) inserted into the BamHI site of the YCpN1 vector (CEN3 ARS1 TRP1; see Nogi et al. (1993)). The mutant was transformed with this library and Trp transformants that can grow on glucose were isolated. One of the corresponding plasmids (pNOY286) contained an insert which was recovered as a 5.6-kb SalI-SmaI fragment using the two outside restriction sites in the vector DNA. The fragment was then inserted between the SalI and SmaI sites of pRS315 to give pNOY272. The 5.6-kb insert contained a single BamHI site and a single PvuII site, and both the 1.8-kb BamHI-SmaI fragment and 1.2-kb PvuII-SmaI fragment were subcloned and sequenced. The latter fragment was sufficient to complement the rrn12 mutation when subcloned into pRS314(pNOY273). The DNA sequence covering the RPA43 coding region was determined for pNOY273. it showed one base deletion within the vector region adjacent to the insert (a deletion of Cys, presumably due to nibling during plasmid construction using the SmaI site), resulting in the open reading frame encoding a fusion protein with 4 amino acids derived from the vector portion replacing the missing 18 amino acids.

Strain D101 was constructed by disrupting one RPA43 allele of the diploid strain YPH499 times YPH500 (see Smid et al. (1995)) into the rpa43Delta::LEU2 null allele using the technique of Rothstein(1983). The 3.2-kb HindIII-PstI fragment containing the disrupted rpa43 gene (rpa43Delta::LEU2) was prepared from p43ADelta-LEU and transformed into a diploid strain constructed by crossing YPH499 with YPH500 (ade2-1 lys2-801 ura3-52 trp1-Delta63 his 3-Delta200 leu2-Delta1) and Leu transformants were selected. The presence of the expected rpa43Delta::LEU2/RPA43 heterozygous structure was examined by genomic Southern hybridization using a digitoxin-labeled pA43 DNA probe. One of the transformants that showed the correct structure was retained. Strains NOY639 and NOY640 were obtained by ethylmethane sulfonate mutagenesis of strain NOY418 as previously described (Nogi et al., 1991b). Growth media were previously described (Mosrin et al., 1990; Nogi et al., 1991b). Briefly, YPD is a complete medium with 2% (w/v) glucose as carbon source, YPGal is YPD where glucose has been replaced by the same amount of filter-sterilized galactose, SD is a glucose-containing synthetic minimal medium that was supplemented with appropriate amino acids and bases to make the uracil, tryptophan, or leucine-omission media. Uracil auxotrophic clones were obtained by selection on the 5-fluororotic acid-containing medium (Boeke et al., 1984).

DNA Sequence Analysis

DNA sequencing was done on alkali-denatured double-stranded DNA by the dideoxy method using a modified T7 DNA polymerase (Sequenase II from U. S. Biochemical Corp.) or using the Taq DyeDeoxy Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, CA). Both strands were sequenced for each DNA sample.

Mutational alteration in the original rrn12(rpa43) mutant strains NOY639 and NOY640 (these strains harbor the same mutation) was determined by recovering the mutant allele by gap repair (Orr-Weaver et al., 1983) and DNA sequencing. pNOY272 (Fig. 1), which complemented the mutation, was digested with NsiI and BglII, and a 3.5-kb fragment including the proximal two-thirds of the RPA43 coding region was removed. The linearized plasmid containing the remaining portion was transformed into the mutant strains, generating Leu/Ura transformants which were selected on galactose medium and screened for non-growth phenotype on glucose medium. Plasmids were prepared from transformants that were unable to grow on glucose medium, and pNOY272 derivatives that failed to complement the rpa43-1 mutation were recovered in E. coli. The rpa43-1 mutation was identified by sequencing both strands of the entire open reading frame of the RPA43 gene in these plasmids.


Figure 1: Organization of the RPA43-RPA190 region. Restriction map of the 17-kb region corresponding to the pNOY16 insert (Mémet et al., 1988; Wittekind et al., 1988) bearing RPA190 and RPA43 and isolated from a genomic library of strain AB320, using colony hybridization against A43-1 (Mémet et al., 1988). The horizontal thin line above the map indicates the region that covers both the sequence previously published for RPA190 (J03530; Mémet et al., 1988) and the one determined in the present work (accession number U22949). Shaded areas correspond to the RPA190 and RPA43 coding sequences, with arrowheads giving their transcriptional orientation. The insets corresponding to the various constructions of the present work are symbolized by horizontal boxes in the lower half of the figure. The open boxes (A43-1, pA43, YCpA43-3, YCpA43-6) denote an inset originating from strain X2180 and isolated by antigenic screening in E. coli (Riva et al., 1986). The filled box (YCpA43-12, pBA43-12) denotes insets subcloned from pNOY16 (see above). The striped boxes (pNOY286, pNOY272, and pNOY273) correspond to insets originating from strain DBY476 and isolated by genetic complementation of the rpa43-1 mutation (see text for explanation). The position of the restriction sites is shown by the short vertical bars (HindIII, ClaI, NsiI, and BamHI are, respectively, abbreviated in H, C, N, and B). Sites denoted by a star originate from the vector cloning sites or from in vitro mutagenesis, as in the case of the SalI* site generated by mutagenizing a pre-existing ClaI site on pNOY16, Wittekind et al.(1988)). MboI sites are shown only for those bordering the pNOY286 insert.



Analysis of RNA Labeled in Vivo

Cells were grown in synthetic galactose medium supplemented with casamino acids, tryptophan, and adenosine at 30 °C to a cell density (A) of approximately 0.2. Each culture was divided into two parts. Glucose was added to one culture to a final concentration of 2%, and the other culture received water, serving as control. After incubation at 30 °C for 1 h, [^3H]uridine (174 mCi/mmol; 100 mCi/ml) was added, and after a 30-min incubation the labeling was stopped by immersing culture flasks into a dry ice-ethanol bath. RNA was isolated and analyzed by electrophoresis on a 2% polyacrylamide, 0.5% agarose composite gel followed by autoradiography as described previously (Nogi et al., 1991a).


RESULTS

Sequence Determination and Physical Linkage between RPA43 and RPA190

RPA43 was first isolated as a A43-1 clone constructed from the S. cerevisiae strain X2180. This clone, obtained by immunological screening of the gt11 bank with polyclonal antibodies raised against A43, produced a polypeptide of 43 kDa (as determined by SDS-polyacrylamide gel electrophoresis) when expressed in Escherichia coli (Riva et al., 1986). A 2.4-kb EcoRI-HindIII fragment of the A43-1 insert was subcloned in pBluescriptKS+, yielding plasmid pA43 (Fig. 1). The DNA sequence of this fragment and of the corresponding regions derived from two other yeast strains, AB320 and DBY476 (see legend of Fig. 1), was determined (see below for the sequence obtained from pNOY272 and pNOY273). The contiguous 2097-base pair DNA sequence (accession number U22949) generated from these determinations contained a 978-base pair uninterrupted open reading frame encoding a 326-amino acid polypeptide. The predicted amino acid sequence is identical in all three strains, but AB320 differs from the other two by a silent G A transition at nucleotide 546 of the open reading frame. There is a perfect match with the amino acid sequences of two peptides (SQAESLPIVSNK and ILDADPL, underlined in Fig. 2) which were isolated from the purified A43 protein after tryptic digestion and whose amino acid sequences were directly determined. (^3)This confirms the original identification of the gene (hereafter called RPA43) based on immunological methods using specific antibodies against A43. The absence of the (A/T)ACTAAC consensus motif present at the branch point of all S. cerevisiae introns identified so far strongly argues that RPA43 is an intron-less gene.


Figure 2: Predicted amino acid sequence, hydrophilicity pattern, and distribution of acidic/basic amino acid residues of A43. Amino acid sequences determined by analyzing two tryptic peptides derived from purified A43 are underlined. The vertical arrows denote sites of truncation corresponding to the lethal rpa43-1 nonsense mutation eliminating the last 110 amino acids of A43, and to the viable mutant form encoded by pNOY273 and its derivative, where the last 18 amino acids are replaced by other amino acids derived from the relevant vectors (see text for explanation). DNA sequence accession number U22949.



In the course of the sequence analysis of RPA43, we found that its initiator ATG is separated by 805 base pairs from a divergently transcribed reading frame, that turned out to be RPA190 (Mémet et al., 1988), encoding the largest subunit (A190) of pol I (Fig. 1). As previously noted, the RPA43-RPA190 intergenic region contained putative RPG and PAC boxes (Mémet et al., 1988; Dequard-Chablat et al., 1991) that could be involved in regulation of the transcription of these genes. This physical linkage cannot be due to an artifact generated by some in vitro recombination event during the preparation of the genomic library, because the three RPA43 clones mentioned above, which were derived from three distinct yeast libraries (see ``Materials and Methods''), all have the same restriction enzyme sites covering this region. In addition, the linkage of RPA43 to RPA190 was also directly demonstrated by nucleotide sequencing of the DNA derived from AB320 (A43-1) and from DBY476 (pNOY286). RPA190 (McCusker et al., 1991) and RPA43 (Riva et al., 1982) were already known to map to chromosome XV.

Properties of the Predicted Amino Acid Sequence of RPA43

The RPA43 open reading frame encodes a protein of 326 amino acids. Its calculated molecular mass (36.2 kDa) is notably smaller than the 43 kDa estimate on SDS-polyacrylamide gel electrophoresis analysis (Buhler et al., 1976), a difference that could merely reflect a somewhat atypical electrophoretic migration of this phosphoprotein (Bréant et al., 1983). The predicted amino acid sequence of A43 has no significant homology to entries of current data banks. Moreover, no significant homology was detected when aligning A43 with known subunits of yeast pol II and pol III in pairwise alignments. There is some similarity between A43 and the pol III-specific subunit C31 (Mosrin et al., 1990) but this is restricted to a hyperacidic COOH-terminal end present in both subunits. In the case of A43, this acidic COOH-terminal domain corresponds to the last 46 residues (with 39% acidic residues). As a matter of fact, A43 is a very hydrophilic protein, with abundant polar residues accounting for 55% of the total sequence. The pI (4.8) calculated from the deduced amino acid of A43 is close to the experimentally determined value of 5.1 (Buhler et al., 1976). It should be noted, however, that A43 is a phosphoprotein and contains an average of four phosphates per molecule (Bréant et al., 1983). The acidic COOH-terminal domain has several phosphorylation sites for casein kinase II. Furthermore, Ser-244 is potentially phosphorylatable by three distinct kinases (cAMP-dependent protein kinase, calmodulin-dependent protein kinase, and phosphorylase kinase).

RPA43 Is an Essential Gene Required for rRNA Synthesis

The rpa43Delta::LEU2 deletion, removing most of the RPA43 coding sequence (Fig. 1), is recessive lethal. This conclusion was first obtained by tetrad analysis using a diploid strain (D101) carrying rpa43Delta::LEU2 on one chromosome and RPA43 on another chromosome. Tetrad dissection showed the 2:2 segregation of viable (RPA43) and non-viable (rpa43Delta::LEU2) spores in the offspring (Fig. 3, left panel). As such, this lethal phenotype could be limited to a defective spore germination phenotype, or due to a negative effect of the deletion on the expression of adjacent RPA190. Both interpretations were ruled out by showing that viable rpa43Delta::LEU2 segregants can be recovered in the D101 offspring when the latter strain bears the centromeric plasmid YCpA43-12 (URA3 RPA43) (Fig. 2, middle panel). As expected, the segregants carrying rpa43Delta::LEU2 invariably harbored the URA3 RPA43 plasmid, and could not lose it as evidenced by their inability to form colonies on 5-fluororotic acid medium which selects for the loss of the URA3 plasmid.


Figure 3: Tetrad analysis of D101 (rpa43Delta::LEU2/RPA43). Left panel, tetrads derived from diploid D101. Spores were isolated by micromanipulation and germinated on YPD. Note the mendelian pattern of two viable and two lethal spores (12 tetrads analyzed and four examples shown). Central panel, tetrads derived from D101 bearing the YCpA43-12 (CEN4 URA3 RPA43) plasmid. More than two viable spores were recovered in most asci, indicating the complementation of rpa43Delta::LEU2 by the YCpA43-12 (CEN4 URA3 RPA43) plasmid (see text for further explanations). Right panel, tetrads derived from D101 bearing pNOY102 (URA3, GAL7-SrDNA). Spores were germinated on YPGal. Note the mendelian segregation of two fast-growing (RPA43) and two slow-growing segregants, the latter bearing the rpa43Delta::LEU2 with partial rescue of growth defect due to the (inefficient) synthesis of S rRNA from the GAL7-SrDNA fusion gene (Nogi et al., 1991a).



The complementation data described above show that A43 is essential for cell growth, but do not prove that this protein is required for rRNA synthesis and thus is a functional component of pol I. The proof was obtained by the demonstration that the lethal phenotype of the RPA43 deletion can be rescued by the presence of pNOY102, which carries the GAL7-SrDNA fusion gene (Nogi et al., 1991b). This fusion gene allows the synthesis of the S rRNA by pol II from the GAL7 promoter in the presence of inducer galactose. As shown in Fig. 3(right panel), spores isolated from strain D101(pNOY102) and germinated on YPGal have a 2:2 segregation of two fast-growing RPA43 spores, and two slow growing spores corresponding to the rpa43Delta::LEU2 segregants rescued by the GAL7-SrDNA fusion. The latter segregants failed to grow when replica plated on glucose containing YPD medium and were also unable to grow on galactose medium in the presence of 5-fluororotic acid, confirming that their growth depends on the presence of this plasmid.

Isolation of the rpa43-1 Mutation

Mutants that depend on the presence of the GAL7-SrDNA gene for growth were isolated and classified into complementation groups by genetic crosses (Nogi et al., 1991b) and the genes representing some of these complementation groups were cloned and characterized (Nogi et al., 1993; Nomura et al., 1993; Keys et al., 1994). Complementation group RRN12 was previously defined by two such mutants, NOY639 and NOY640. (^4)To clone and characterize the corresponding gene, a yeast genomic library (prepared from strain DBY746) was introduced into mutant NOY639, and transformants able to grow on glucose media (where the GAL7 promoter is repressed) were recovered. A plasmid recovered from one of them (pNOY286) was analyzed further. Sequencing of the subcloned DNA fragments (pNOY272 and pNOY273; see Fig. 1) responsible for the complementation revealed the presence of the amino-terminal portion of the RPA190 gene (in pNOY272) and an open reading frame containing the first 308 codons of the RPA43 coding sequence, but ending with GATC (nucleotide 921-924; the Ala of the first ATG of the RPA43 open reading frame is the +1) followed by the sequence of the original cloning vector adjacent to the BamHI site (GGATCC) used for construction of the DNA library. Thus, the RPA43 insert carried by the original complementing plasmid (pNOY286) as well as its derivatives are actually bearing a mutant form of RPA43, that encodes A43 down to the isoleucine residue at position 308 but lacks the carboxyl-terminal 18 amino acids. In pNOY273, the missing 18 amino acids are replaced by four amino acids, PGIH, translated from nucleotide sequence derived from the multicloning site of the vector (pRS314) used to construct this plasmid. This generated a small decrease (about 1.5 kDa) in the size of A43 which was confirmed by Western immunoblot analysis of extracted prepared from rrn12 mutants carrying pNOY273 (data not shown). The growth rates of the rrn12 mutants carrying pNOY273 was only slightly (about 10%) slower than the growth rate of the parent wild type strain, and the carboxyl-terminal 18-amino acid portion is therefore not critical to the function of A43.

The mutation carried by mutant NOY639 was recovered by gap repair using plasmid pNOY272 carrying the cloned RPA43 (missing the COOH-terminal 18 amino acids), as described under ``Materials and Methods.'' The mutation carried by both NOY639 and NOY640 was identified to be a G to A transition at nucleotide +650 that changes the UGG Trp codon at amino acid position 217 to a UAG nonsense codon. The results demonstrate that the rrn12 mutation is in fact in the RPA43 gene, and that truncation of A43 (326 amino acids) at the position distal to His-216 by a nonsense mutation leads to lethality to yeast cells. The presence of the truncated A43 protein fragment in the mutant cells (under permissive growth conditions, that is, mutant cells growing in galactose medium using the GAL7-SrDNA fusion gene and pol II) was, in fact, demonstrated by Western immunoblot analysis of extracts using antiserum against A43, and its size relative to the size of A43 was roughly consistent with the position of the nonsense codon (data not shown). We have not examined the question of whether (defective) pol I missing the intact A43 exists stably in these mutant cells, and if so, the observed truncated A43 fragment is associated with the defective pol I. In any event, we renamed RRN12 as RPA43 and the mutation carried by NOY639 and NOY640 is now designated as rpa43-1.

Direct Demonstration of Defects in S rRNA Synthesis in the rpa43-1 Mutant Strain

As described above, mutants carrying rpa43Delta::LEU2 or rpa43-1 fail to grow on glucose media, but were able to grow on galactose media, if they carried the GAL7-SrDNA fusion gene on a suitable multicopy plasmid. This indicated that A43 is essential for S rRNA synthesis by pol I in vivo. We confirmed this conclusion directly by [^3H]uridine pulse-labeling experiments using a rpa43-1 mutant strain. Both the mutant (NOY639) and the control wild-type (NOY418) strains were grown in synthetic galactose medium, and [^3H]uridine pulse labeling experiments were carried out with and without prior repression of the GAL7 promoter by glucose, as was done in previous studies (Nogi et al., 1991a, 1991b). As shown in Fig. 4, synthesis of large rRNA (18 S, 25 S, 5.8 S, and other precursor rRNAs) was strongly inhibited by glucose relative to synthesis of 5 S RNA and tRNAs, showing that rpa43 -1 abolishes the synthesis of large rRNA by pol I specifically without significant effect on 5 S RNA and tRNA synthesis.


Figure 4: Polyacrylamide-agarose gel electrophoresis of RNA synthesized in a rpa43-1 mutant (NOY639) and the parent (NOY418) strains growing in galactose with and without prior glucose addition. Parent strain NOY418 (lanes 1 and 2) and rpa43-1 mutant NOY639 (lanes 3 and 4) were grown at 30 °C in galactose medium. At a cell density (A) of approximately 0.2, cultures were divided into two parts: and glucose (final concentration 2%) was added to one part (lanes 2 and 4), the other received water, serving as control (lanes 1 and 3). At 1 h after glucose addition, cells were pulse-labeled with [^3H]uridine for 30 min. RNA was isolated from each culture, and samples containing equal amounts (approximately 1 times 10^5 cpm) of [^3H]RNA were analyzed by electrophoresis on a polyacrylamide-agarose composite gel. An autoradiogram of the dried gel is shown. We note that autoradiograms obtained after longer gel exposures indicated that 5.8 S rRNA synthesis in the mutant was inhibited by glucose, as was that of 18 S and 25 S rRNAs.




DISCUSSION

It has been known that highly purified preparations of yeast pol I, but not pol II or pol III, contained the A43 protein. However, some pol I preparations lacking both A49 and A43 retained catalytic activity as assayed with nonspecific DNA template (Hager et al., 1977). Although A49 has since then been shown to be a genuine subunit of pol I (Liljelund et al., 1992), the possibility of a fortuitous co-purification of A43 with pol I could not be ruled out. We have now sequenced and characterized the corresponding gene, RPA43. Its inactivation by a nonsense mutation or by an extended internal deletion is lethal, but cells carrying these mutations can be rescued by introduction of the GAL7-SrDNA fusion gene and its transcription by pol II in the presence of inducer galactose. The results indicate that the absence of intact A43 leads to failure to synthesize S rRNA using pol I, and this conclusion was confirmed directly by [^3H]uridine pulse labeling experiments using a rpa43 nonsense mutant. Thus, A43 is essential for S rRNA synthesis by pol I in vivo, and hence, must represent an essential subunit of pol I, even if it does not appear to be required for pol I-dependent transcription of nonspecific DNA templates (Hager et al., 1977). It will be interesting to re-investigate the pol I preparations lacking A43 using in vitro transcription assays that allow specific transcription initiation of the natural pol I promoter (Lue and Kornberg, 1990; Riggs and Nomura, 1990; Schultz et al., 1991; Keys et al., 1994).

Genes encoding distinct subunits of the same heteromultimeric enzyme are usually dispersed on the yeast genome, and this also applies to RNA polymerase subunits (Young, 1991; Thuriaux and Sentenac, 1992). Surprisingly, however, RPA43 is physically linked to RPA190. The two genes are divergently transcribed, and their coding regions are separated by 805 base pairs containing putative RPG and PAC boxes (Mémet et al. 1988; Dequard-Chablat et al., 1991). Thus, as in the case of the L46-L24 ribosomal protein gene pair (Kraakman et al., 1989), these two genes might be co-regulated using common upstream activating sequences such as the putative RPG and PAC boxes, thereby helping balance synthesis of these two essential pol I subunit proteins.

Early studies showed that A43 is not immunologically related to yeast pol II or pol III or their purified subunits, suggesting that A43 is unique to pol I (Huet et al., 1982). The present study extends this conclusion by showing that A43 has no significant sequence homology to any other entries in current data banks and is, in particular, unrelated to any of the 12 subunits of yeast pol II and to the 14 genetically characterized subunits of yeast pol III (Young (1991), Thuriaux and Sentenac(1992), and Sadhale and Woychik(1994), and references therein). However, there is a poorly characterized polypeptide of 37 kDa, C37, that is present in some catalytically active preparations of yeast pol III and might thus be a genuine subunit of that enzyme (Huet et al., 1985). The corresponding gene has not yet been identified.

As mentioned in the Introduction, there are three other subunits, A49, A34, and A14, in addition to A43, which are unique to pol I. However, the genes for A49, A34, and A14 can be disrupted with only limited adverse effects on cell growth (Liljelund et al., 1992; Nogi et al., 1993; Smid et al., 1995),^2 while the gene for A43 is essential. Therefore, A43 appears to be special and may have some important function(s) specific to pol I. For example, it may directly interact with the yeast equivalents of the SL1 and UBF1 initiation factors that are well characterized in vertebrate in vitro transcription systems (Reeder, 1992; Eberhard et al., 1993; Radebaugh et al., 1994; Zomerdijk et al., 1994), or to the products of several RRN genes (Keys et al., 1994) that are known to be specifically required for pol I activity in vivo or some other unidentified pol I-specific regulatory factors. A similar role was proposed for a complex of three pol III-specific subunits, C82, C34, and C31 (Thuriaux and Sentenac, 1992; Werner et al., 1993). Curiously, A43 and the C31 subunit of yeast pol III (Mosrin et al., 1990), although otherwise unrelated, share a strongly acidic COOH-terminal domain of about 40 residues. Deleting the last 16 amino acids of C31 leads to a conditional growth phenotype and produces a mutant enzyme that is affected in transcription initiation, but not termination or elongation, suggesting that it could be altered in its interaction with components of the pol III-specific initiation factor TFIIIB (Thuillier et al., 1995). In the case of A43, the functional significance of the acidic tail is unclear. Removing the COOH-terminal 18 amino acids representing nearly half of the acidic tail gives only a weak negative effect on its function as judged by the ability of pNOY273 (and other related plasmids) to complement the rpa43-1 mutation. Another interesting feature of A43 is that it is a phosphoprotein with an average of four phosphorylated residues per molecule (Bréant et al., 1983). With the complete amino acid sequence of A43 now deduced from the nucleotide sequence, it becomes possible to identify the phosphorylated residues and then design experiments to examine the functional and/or regulatory significance of the phosphorylation, thereby clarifying the function of this essential component of the rRNA synthesis machinery.


FOOTNOTES

*
The work carried out in M. Nomura's laboratory was supported by National Institutes of Health Grant R37GM35949. Work done in A. Sentenac's laboratory was partly funded by Grant BIO2-CT92-0090 from the European Union. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBank(TM)/EMBL Data Bank with accession number(s) U22949[GenBank].

§
To whom correspondence should be addressed: Bât. 142, CEA Saclay, F91191 Gif sur Yvette, cedex, France. thuriaux{at}jonas.saclay.cea.fr.

(^1)
The abbreviations used are: pol I, II, and III, polymerase I, II, and III; kb, kilobase pair(s).

(^2)
O. Gadal, S. Mariotte, and P. Thuriaux, manuscript in preparation.

(^3)
M. Riva, personal communication.

(^4)
L. Vu, K. Sutton, and M. Nomura, unpublished experiments.


ACKNOWLEDGEMENTS

We thank Karen Sutton for her participation in isolation and complementation analysis of two rrn12(rpa43) mutants described in this paper, Claire Boschiero, Catherine Doira, and Eric Quémeneur for their contribution to DNA sequencing, and Michel Riva for communicating the peptidic sequence of the two trypic fragments of A43.


REFERENCES

  1. Boeke, J. D., Lacroute, F. & Fink, G. R. (1984) Mol. Gen. Genet. 197,345-346 [Medline] [Order article via Infotrieve]
  2. Bréant, B., Buhler, J. M., Sentenac, A. & Fromageot, P. (1983) Eur. J. Biochem. 130,247-251 [Abstract]
  3. Buhler, J. M., Iborra, F., Sentenac, A. & Fromageot, P. (1976) J. Biol. Chem. 251,1712-1717 [Abstract]
  4. Carles, C., Treich, I., Bouet, F., Riva, M. & Sentenac, A. (1991) J. Biol. Chem. 266,24092-24096 [Abstract/Free Full Text]
  5. Dequard-Chablat, M., Riva, M., Carles, C. & Sentenac, A. (1991) J. Biol. Chem. 266,15300-15307 [Abstract/Free Full Text]
  6. Eberhard, D., Tora, L., Egly, J. M. & Grummt, I. (1993) Nucleic Acids Res. 21,4180-4186 [Abstract]
  7. Hager, G. L., Holland, M. J. & Rutter, W. J. (1977) Biochemistry 16,1-7 [Medline] [Order article via Infotrieve]
  8. Huet, J., Sentenac, A. & Fromageot, P. (1982) J. Biol. Chem. 257,2613-2618 [Free Full Text]
  9. Huet, J., Riva, M., Sentenac, A. & Fromageot, P. (1985) J. BIol. Chem. 260,15304-15310 [Abstract/Free Full Text]
  10. Keys, D., Vu, L., Steffan, J. S., Dodd, J. A., Yamamoto, R. T., Nogi, Y. & Nomura, M. (1994) Genes & Dev. 8,2349-2362
  11. Kraakman, L. S., Mager, W. H., Maurer, K. T. C., Nieuwint, T. M. & Planta, R. J. (1989) Nucleic Acids Res. 17,9693-9706 [Abstract]
  12. Lalo, D., Carles, C., Sentenac, A. & Thuriaux, P. (1993) Proc. Natl. Acad. Sci. U. S. A. 90,5524-5528 [Abstract]
  13. Langer, D., Hain, J., Thuriaux, P. & Zillig, W. (1995) Proc. Natl. Acad. Sci. U. S. A. 92,5768-5772 [Abstract/Free Full Text]
  14. Liljelund, P., Mariotte, S., Buhler, J. M. & Sentenac, A. (1992) Proc. Natl. Acad. Sci. U. S. A. 89,9302-9305 [Abstract]
  15. Lue, N. F. & Kornberg, R. D. (1990) J. Biol. Chem. 265,18091-18094 [Abstract/Free Full Text]
  16. Mann, C., Buhler, J. M., Treich, I. & Sentenac, A. (1987) Cell 48,627-637 [CrossRef][Medline] [Order article via Infotrieve]
  17. McCusker, J. H., Yamagishi, M., Kolb, J. M. & Nomura, M. (1991) Mol. Cell. Biol. 11,746-753 [Medline] [Order article via Infotrieve]
  18. Mémet, S., Gouy, M. Marck, C., Sentenac, A. & Buhler, J. M. (1988) J. Biol. Chem. 263,2830-2839 [Abstract/Free Full Text]
  19. Mosrin, C., Riva, M. Beltrame, M., Cassar, E., Sentenac, A. & Thuriaux, P. (1990) Mol. Cell. Biol. 10,4737-4743 [Medline] [Order article via Infotrieve]
  20. Nogi, Y., Yano, R. & Nomura, M. (1991a) Proc. Natl. Acad. Sci. U. S. A. 88,3962-3966 [Abstract]
  21. Nogi, Y., Vu, L. & Nomura, M. (1991b) Proc. Natl. Acad. Sci. U. S. A. 88,7026-7030 [Abstract]
  22. Nogi, Y., Yano, R. Dodd, J. Carles, C. & Nomura, M. (1993) Mol. Cell. Biol. 13,114-122 [Abstract]
  23. Nomura, M., Nogi, Y., Yano, R., Oakes, M., Keys, D. A., Vu, L. & Dodd, J. (1993) in The Translational Apparatus (Nierhaus, K. H., Franceschi, F., Subramanian, A. R., Erdmann, V. A., and Wittmann-Liebold, B., eds) pp. 89-99, Plenum Press, New York
  24. Orr-Weaver, T. L., Szostak, J. W. & Rothstein, R. J. (1983) Methods Enzymol. 101,228-245 [Medline] [Order article via Infotrieve]
  25. Radebaugh, C. A., Matthews, J. L., Geiss, G. K., Liu, F. Wong, J. M. Bateman, R., Camier, S., Sentenac, A. & Paule, M. R. (1994) Mol. Cell. Biol. 14,597-605 [Abstract]
  26. Reeder, R. H. (1992) in Transcriptional Regulation (McKnight, S. L. and Yamamoto K. R., eds) Vol. 2, pp. 315-348, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
  27. Riggs, D. L. & Nomura, M. (1990) J. Biol. Chem. 265,7596-7603 [Abstract/Free Full Text]
  28. Riva, M., Buhler, J. M., Sentenac, A., Fromageot, P. & Hawthorne, D. C. (1982) J. Biol. Chem. 257,4570-4577 [Abstract/Free Full Text]
  29. Riva, M., Mémet, S., Micouin, J. Y., Huet, J., Treich, I. Dassa, J., Young, R., Buhler, J. M., Sentenac, A. & Fromageot, P. (1986) Proc. Natl. Acad. Sci. U. S. A. 83,1554-1558 [Abstract]
  30. Rothstein, L. R. (1983) Methods Enzymol. 101,202-210 [Medline] [Order article via Infotrieve]
  31. Sadhale, P. P. & Woychik, N. A. (1994) Mol. Cell. Biol. 14,6164-6170 [Abstract]
  32. Schultz, M. C., Choe, S. Y. & Reeder, R. H. (1991) Proc. Natl. Acad. Sci. U. S. A. 88,1004-1008 [Abstract]
  33. Smid, A., Riva, M., Bouet, F., Sentenac, A. & Carles, C. (1995) J. Biol. Chem. 270,13534-13540 [Abstract/Free Full Text]
  34. Thuillier, V., Stettler, S., Sentenac, A., Thuriaux, P. & Werner, M. (1995) EMBO J. 14,351-359 [Abstract]
  35. Thuriaux, P. & Sentenac, A. (1992) in The Molecular and Cellular Biology of the Yeast Saccharomyces (Jones, E. W., Pringle, J. R., and Broach, J. R., ed) Vol. 2, pp. 1-48, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  36. Treich, I., Carles, C., Riva, M. & Sentenac, A. (1992) Gene Exp. 2,31-37
  37. Valenzuela, P., Bell, G. I., Weinberg, B. F. & Rutter, W. J. (1976) Biochem. Biophys. Res. Commun. 71,1319-1325 [Medline] [Order article via Infotrieve]
  38. Warner, J. R. (1989) Microbiol. Rev. 53,256-271
  39. Werner, M., Chaussivert, N., Willis, I. M. & Sentenac, A. (1993) J. Biol. Chem. 268,20721-20724 [Abstract/Free Full Text]
  40. Wittekind, M., Dodd, J., Vu, L., Kolb, J. M. Buhler, J. M., Sentenac, A. & Nomura, M. (1988) Mol. Cell. Biol. 8,3997-4008 [Medline] [Order article via Infotrieve]
  41. Woychik, N. A. & Young, R. A. (1990) J. Biol. Chem. 265,17816-17819 [Abstract/Free Full Text]
  42. Woychik, N. A., Liao, S. M., Kolodziej, P. A. & Young, R. A. (1990) Genes & Dev. 4,313-323
  43. Woychik, N. A., Lane, W. S. & Young, R. A. (1991) J. Biol. Chem. 266,19053-19055 [Abstract/Free Full Text]
  44. Yano, R. & Nomura, M. (1991) Mol. Cell. Biol. 11,754-764 [Medline] [Order article via Infotrieve]
  45. Young, R. A. (1991) Annu. Rev. Biochem. 60,689-715 [CrossRef][Medline] [Order article via Infotrieve]
  46. Zomerdijk, J. C. B. M., Beckmann, H., Comai, L. & Tjian, R. (1994) Science 266,2015-2018 [Medline] [Order article via Infotrieve]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.